RASA LILIJA BUNTINAS MD NPI 1902880966

NPI Details

Rasa Lilija Buntinas, MD is a hematology and oncology internal medicine in Cedar Rapids, IA with 33 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Rasa Lilija Buntinas, MD NPI is 1902880966. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: LOYOLA UNIVERSITY OF CHICAGO, STRITCH SCHOOL OF MEDICINE
Graduation Year:1993

The provider's business location address is:

202 10TH STREET SE
CEDAR RAPIDS, IA
ZIP 52403-404
Phone: (319) 297-2900
Fax: (319) 297-2969

The NPI 1902880966 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, gadoterate meglumine, 0.1 ml (HCPCS:A9575)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Injection, potassium chloride, per 2 meq (HCPCS:J3480)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Ferritin (blood protein) level (HCPCS:82728)
• Vitamin d-3 level (HCPCS:82306)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Magnesium level (HCPCS:83735)
• Unclassified drugs (HCPCS:J3490)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Phosphate level (HCPCS:84100)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Red blood count automated, with additional calculations (HCPCS:85046)
• Mri scan of both breasts (HCPCS:77049)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Ct scan of chest with contrast (HCPCS:71260)
• Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
• Uric acid level, blood (HCPCS:84550)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Extended patient service without direct patient contact, first hour (HCPCS:99358)
• Mri scan of brain before and after contrast (HCPCS:70553)
• Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or (HCPCS:G2212)
• Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
• Parathormone (parathyroid hormone) level (HCPCS:83970)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)

The enumeration date for this NPI number is 12/2/2005 and was last updated on 9/11/2013.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.